Skip to main content

Ultragenyx Pharmaceutical Inc.

RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001515673

In the last 90 days, Ultragenyx Pharmaceutical Inc. insiders filed 0 open-market purchases and 5 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $3.55B in total; no superinvestor holds it.

Politicians who traded RARE

Since 2020, newest trade first. Shares and options by default, including trades reported under an earlier ticker.

Trades
4
Filings
4
Politicians
1
Buys / sells
4 / 0
Estimated volume
$32.0K
Sum of range midpoints
Politicians who traded RARE
PoliticianTradesBuys / sellsEst. volumeLast tradedLast filed
44 / 0$32.0KMar 3, 2026Apr 7, 2026

Trades

Reported trades in Ultragenyx Pharmaceutical Inc., newest filings first.

Politician trades
PoliticianAssetTypeOwnerTradedFiledDelayAmountSource
RAREUltragenyx Pharmaceutical Inc. - Common StockBuySelfMar 3, 2026Apr 7, 202635 days$1K-$15KFiling
RAREUltragenyx Pharmaceutical Inc. - Common StockBuySelfFeb 18, 2026Mar 9, 202619 days$1K-$15KFiling
RAREUltragenyx Pharmaceutical Inc. - Common StockBuySelfAug 8, 2025Sep 12, 202535 days$1K-$15KFiling
RAREUltragenyx Pharmaceutical Inc. - Common StockBuySelfJul 15, 2025Aug 14, 202530 days$1K-$15KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.